Delivery Order SPE2DB24D2205-SPE2DB25FEBQZ

Award Date 4/29/25
Potential Completion Date 5/20/25
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,352.49, is for the supply of a specific pharmaceutical product, Erleada 240 mg tablets, with a performance period through May 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,235.16, is for the delivery of the prescription medication Erleada 60 mg tablets. The contract has a firm fixed price pricing type and a completion date of May 19, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,352.49, is for the supply of 4,567,942,273 units of the pharmaceutical product ERLEADA 240 MG TABLET. The contract is a firm fixed-price, non-set-aside award with a performance period through May 7, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,612.56, is for the delivery of 120 tablets of the drug ERLEADA 60 MG. The contract has a firm fixed price pricing type and a completion date of November 14, 2024. This delivery order is part of a larger $999,999,999 IDC that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $7,106.87 firm-fixed-price contract is for the delivery of 120 tablets of the prescription medication Erleada (60 mg) to support DoD and other government healthcare programs. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,106.87, is for the provision of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. The contract is a firm fixed price delivery order with a period of performance through May 26, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide the medication Erleada 60 mg Tablet. The contract has a ceiling value of $7,306.27 and an ultimate completion date of August 9, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 120 tablets of the prescription medication Erleada 60 mg. The contract has a firm fixed price of $7,106.87 and a completion date of May 10, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,950.04, is for the delivery of 120 tablets of the medication Erleada 60 mg. The contract is a firm fixed-price, delivery order type, with a completion date of February 13, 2023. It is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. (AmerisourceBergen) for the supply of Erleada 60 mg tablets. The contract has a ceiling value of $7,306.27 and a period of performance through September 18, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with various federal agencies, including a...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEBQZ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,352.49, is for the delivery of 4,568,076,666 units of the prescription medication Erleada 240 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 20, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely one of many made under that overarching IDC to support military and government healthcare programs.

Generated 7/29/25, 9:53 AM